ARTV · Artiva Biotherapeutics, Inc.
$10.93
-0.21 (-1.89%)
At close · Aug 21
Market Cap
$544.64M
Shares
48.89M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
-$83.87M
-28.3%
FY2025
Operating Margin
-26805.58%
-26714pp
FY2024
Diluted EPS
-$3.43
+41%
FY2025
Operating Cash Flow
-$76.75M
-39.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| — | $0 | $251K | $33.49M | |
| $75.86M | $69.54M | $50.33M | $50.25M | |
| $20.29M | $20.27M | $17.21M | $13.91M | |
| — | $2.6M | $2.43M | $2.27M | |
| $96.15M | $89.81M | $67.53M | $64.16M | |
| -$96.15M | -$89.81M | -$67.28M | -$30.67M | |
| — | — | -26805.58% | -91.58% | |
| — | -$87.21M | -$64.85M | -$28.41M | |
| $5.33M | $5.95M | $1.91M | $2.02M | |
| — | — | -$65.37M | -$28.65M | |
| — | $0 | $0 | $72K | |
| -$90.82M | -$83.87M | -$65.37M | -$28.72M | |
| — | — | -26045.02% | -85.75% | |
| -$90.84M | -$83.63M | -$65.81M | -$28.41M | |
| USD/shares | — | -$3.43 | -$5.81 | -$35.78 |
| USD/shares | — | -$3.43 | -$5.81 | -$35.78 |
| shares | — | 24.44M | 11.26M | 802.75K |
| shares | — | 24.44M | 11.26M | 802.75K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.79×
EV/EBIT
—
Peer median 13.01×
P/E (TTM)
—
Peer median 12.84×
Peer medians compare against the 315 similar-size Biotechnology companies (of 546 listed).
Key facts
CIK
1817241
CUSIP
04317A107
13F (30d)
74 filings
73 filers
Visit website
Investor relations